Check-Cap Announces Oral Presentation at Digestive Disease Week? 2014 on Safety and Proof of Concept of World's First Non-Invasive and Preparation-Free Imaging Test for Colorectal Cancer - Applied Cli

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Check-Cap Announces Oral Presentation at Digestive Disease Week? 2014 on Safety and Proof of Concept of World's First Non-Invasive and Preparation-Free Imaging Test for Colorectal Cancer


Check-Cap Announces Oral Presentation at Digestive Disease Week® 2014 on Safety and Proof of Concept of World's First Non-Invasive and Preparation-Free Imaging Test for Colorectal Cancer

PR Newswire

ISFIYA, Israel, May 2, 2014 /PRNewswire/ -- Check-Cap, Ltd., announced today that a study underscoring the safety and proof of concept of the Check-Cap high-resolution colon imaging system, designed to be the world's first preparation-free, non-invasive screening test for colorectal cancer and clinically-significant pre-cancerous polyps will be presented at a research forum during the Digestive Disease Week® (DDW®) 2014 annual meeting.  DDW will take place from May 4 to 6, 2014, at McCormick Place, Chicago, IL.

Session: Novel and Experimental Endoscopy Research Forum, Safety and Proof of Concept Demonstrated With a Novel Prep-Less X-Ray Imaging Capsule for Colon Cancer Screening 

Abstract:  808
Presenter: Menachem Moshkowitz; Nadir Arber
Date: Monday, May 5, 2014
Time:  4:00PM - 5:30PM CT
Location: McCormick Place - S505

"For many patients, the most difficult and unpleasant part of undergoing a colonoscopy is the preparation required with traditional colonoscopes," said Guy Neev, CEO, Check-Cap Ltd. "We believe that as the first high-resolution screening modality for colorectal cancer that requires no bowel cleansing or other aggressive preparation, the Check-Cap imaging system has the potential to improve patient compliance to colon cancer screening guidelines.  This is the first clinical data presentation in support of this new modality and a significant milestone for the company."

A video accompanying this press release is available at:
http://www.youtube.com/watch?v=sPL-6zp1gvs

Check-Cap, Ltd. did not provide financial support for the above scientific sessions and did not influence the content in any way. However, research presented within these scientific sessions may have been supported by Check-Cap, Ltd.

All data being presented during DDW is embargoed until the date and time of presentation, which is 4:48 p.m. CT for this presentation.

About DDW
Digestive Disease Week® (DDW®) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 3 – 6, 2014, at McCormick Place, Chicago, Illinois. The meeting showcases more than 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at www.ddw.org.

About Check-Cap Ltd.
Check-Cap is a medical diagnostics company focused on the development of gastrointestinal imaging devices. The company's lead product is an endoscopy capsule that utilizes proprietary, ultra-low-energy X-ray-based measurement technology to safely generate high-resolution, 3-dimensional imagery of the colon without cleansing or other aggressive bowel preparation. This patient-friendly solution is designed to increase compliance with screening recommendations.  The Check-Cap System is not cleared for marketing in the U.S.

MEDIA CONTACT:
David Carey
Lazar Partners Ltd.
212-867-1768
dcarey@lazarpartners.com 

SOURCE Check-Cap, Ltd.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document

Click here